Spectrum Dynamics Medical, a global leader in digital nuclear medicine imaging solutions, today announced that it has ...

Dec. 4, 2002 (Chicago) - A radiopharmaceutical-imaging agent - ioflupane (I123-FP-CIT) - used with single photon emission computed tomography (SPECT) is "98% accurate" for early diagnosis of Parkinson ...

The global SPECT scanning services market is poised for transformative growth, expected to reach USD 2,425.2 million by 2025 and expanding steadily at a CAGR of 4.6% to hit USD 3,819.5 million by 2035 ...

SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced the publication of the first human SPECT images ...

MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce ...

The NOBLE (Nobody Left Behind) Registry (NOBLE) is a global real-world evidence (RWE) study that aims to improve equity of access to state-of-the-art prostate cancer imaging. NOBLE is a collaboration ...

The global single-photon emission computed tomography (SPECT) market is on a steady growth trajectory, with its valuation projected to rise from USD 2.28 billion in 2021 to USD 4.76 billion by 2032, ...